Bone turnover in patients with endogenous Cushing's syndrome before and after successful treatment

Osteoporosis International

Volumn 21, Issue 4, 2010, Pages 637-645

  Szappanos, A ^a   Toke, J ^a   Lippai, D ^a   Patocs A ^b   Igaz, P ^a   Szucs N ^a   Futo L ^c   Glaz E ^a   Racz K ^a   Toth M ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c Markhot Ferenc Hospital   (Hungary)

Author keywords

Bone formation; Bone resorption; Cushing's syndrome; Diagnostic sensitivity; Follow up after cure; Osteocalcin

Indexed keywords

CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN; ESTRADIOL; GLUCOCORTICOID; HYDROCORTISONE; OSTEOCALCIN;

ADOLESCENT; ADRENAL CORTEX INSUFFICIENCY; ADRENALECTOMY; ADULT; AREA UNDER THE CURVE; ARTICLE; BONE METABOLISM; BONE TURNOVER; CHEMOLUMINESCENCE; CLINICAL FEATURE; CONTROLLED STUDY; CUSHING SYNDROME; DIABETES MELLITUS; DISEASE COURSE; DISEASE MARKER; FEMALE; FOLLOW UP; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOGONADOTROPIC HYPOGONADISM; MAJOR CLINICAL STUDY; MALE; MYOPATHY; OSSIFICATION; OSTEOLYSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; BONE REMODELING; COLLAGEN TYPE I; CUSHING SYNDROME; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; OSTEOCALCIN; PEPTIDES; POSTOPERATIVE PERIOD; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77950955995     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-009-0978-y     Document Type: Article

References (27)

1. Mancini T, Doga M, Mazziotti G et al (2004) Cushing's syndrome and bone. Pituitary 7:249-252
2. VestergaardP,LindholmJ,JørgensenJOetal(2002) IncreasedriskofosteoporoticfracturesinpatientswithCushing'ssyndrome. EurJEndocrinol146:51-56(Pubitemid34126419)
3. PiovesanA,TerzoloM,ReimondoGetal(1994) BiochemicalmarkersofboneandcollagenturnoverinacromegalyorCushing'ssyndrome. HormMetabRes26:234-237(Pubitemid24162468)
4. Di Somma C, Pivonello R, Loche S et al (2002) Severe impairment of bonemass and turnover in Cushing's disease: comparison between childhood-onset and adulthood-onset disease. Clin Endocrinol 56:153-158 (Pubitemid 34233953)
5. Francucci CM, Pantanetti P, Garrapa GG et al (2002) Bone metabolism and mass in women with Cushing's syndrome and adrenal incidentaloma. Clin Endocrinol 57:587-593 (Pubitemid 35316974)
6. Cortet B, Cortet C, Blanckaert F et al (2001) Quantitative ultrasound of bone and markers of bone turnover in Cushing's syndrome. Osteoporos Int 12:117-123 (Pubitemid 32244664)
7. SartorioA,AmbrosiB,ColomboPetal(1988) OsteocalcinlevelsinCushing'sdiseasebeforeandaftertreatment.HormMetabRes20: 70(Pubitemid18053238)
8. Hermus AR, Smals AG, Swinkels LM et al (1995) Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. J Clin Endocrinol Metab 80:2859-2865
9. KristoC,GodangK,UelandTetal(2002)Raisedserumlevelsofinterleukin- 8andinterleukin-18inrelation-bonemetabolisminendogenousCushing'ssyndrome. EurJEndocrinol146:389-395(Pubitemid34257650)
10. Kristo C, Jemtland R, Ueland T et al (2006) Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: a prospective, long-term study. Eur J Endocrinol 154:109-118 (Pubitemid 43250744)
11. Osella G, Terzolo M, Reimondo G et al (1997) Serum markers of bone and collagen turnover in patients with Cushing's syndrome and in subjects with adrenal incidentalomas. J Clin Endocrinol Metab 82:3303-3307 (Pubitemid 27419076)
12. Tauchmanovà L, Pivonello R, Di Somma C et al (2006) Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status. J Clin Endocrinol Metab 91:1779-1784
13. Chiodini I, Carnevale V, Torlontano M et al (1998) Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing's syndrome. J Clin Endocrinol Metab 83:1863-1867 (Pubitemid 28496307)
14. Godang K, Ueland T, Bollerslev J (1999) Decreased bone area, bone mineral content, formative markers, and increased bone resorptive markers in endogenous Cushing's syndrome. Eur J Endocrinol 141:126-131 (Pubitemid 29402215)
15. ChiodiniI,TorlontanoM,CarnevaleVetal(2008) Skeletalinvolvementinadultpatientswithendogenoushypercortisolism. JEndocrinolInvest31:267-276(Pubitemid351638408)
16. Di Somma C, Pivonello R, Loche S et al (2003) Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study. Clin Endocrinol 58:302-308 (Pubitemid 36308118)
17. ScommegnaS,GreeningJP,StorrHLetal(2005) BonemineraldensityatdiagnosisandfollowingsuccessfultreatmentofpediatricCushing' sdisease.JEndocrinolInvest28:231-235(Pubitemid43162770)
18. Leong GM, Abad V, Charmandari E et al (2007) Effects of childand adolescent-onset endogenous Cushing syndrome on bone mass, body composition, and growth: a 7-year prospective study into young adulthood. J Bone Miner Res 22:110-118 (Pubitemid 46032603)
19. Füto L, Toke J, Patócs A et al (2008) Skeletal differences in bone mineral area and content before and after cure of endogenous Cushing's syndrome. Osteoporos Int 19:941-949
20. Minetto M, Reimondo G, Osella G et al (2004) Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing's syndrome. Osteoporos Int 15:855-861 (Pubitemid 39506451)
21. Karavitaki N, Ioannidis G, Giannakopoulos F et al (2004) Evaluation of bone mineral density of the peripheral skeleton in pre- and postmenopausal women with newly diagnosed endogenous Cushing's syndrome. Clin Endocrinol 60:264-270 (Pubitemid 38200910)
22. Ohmori N, Nomura K, Ohmori K et al (2003) Osteoporosis is more prevalent in adrenal than in pituitary Cushing's syndrome. Endocr J 50:1-7 (Pubitemid 36305842)
23. Cooper MS, Syddall HE, Fall CH et al (2005) Circulating cortisone levels are associated with biochemical markers of bone formation and lumbar spine BMD: the Hertfordshire Cohort Study. Clin Endocrinol 62:692-697
24. van Schoor NM, Dennison E, Lips P et al (2007) Serum fasting cortisol in relation to bone, and the role of genetic variations in the glucocorticoid receptor. Clin Endocrinol (Oxf) 67:871-878 (Pubitemid 350135130)
25. MajnikJ,SzücsN,PatócsAetal(2004) Effectofsingledosesofdexamethasoneandadrenocorticotrophormoneonserumbonemarkers inhealthysubjectsandinpatientswithadrenalincidentalomasandCushing'ssyndrome. JEndocrinolInvest27:747-753(Pubitemid39619062)
26. Nieman LK, Biller BM, Findling JW et al (2008) The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:1526-1540 (Pubitemid 351656485)
27. Elamin MB, Murad MH, Mullan R et al (2008) Accuracy of diagnostic tests for Cushing's syndrome: a systematic review and metaanalyses. J Clin Endocrinol Metab 93:1553-1562 (Pubitemid 351656487)